From: Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction
Caverstem intervention
Baseline (range)*
3 month (range)*
6 month (range)*
1.0 low dose
8 (5–16)
11 (5–25)
10 (5–22)
1.0 high dose
9 (5–16)
12 (5–19)
12 (5–20)
2.0
9 (5–15)
18 (10–24)**
18 (10–23)**